| ORGN | Monday, 27 March 2006 | ||
8:30 AM-12:00 PM Georgia World Congress Center -- C303/304/305, Oral | |||
The Role of Organic Synthesis in Early Clinical Drug Development | |||
| Organizer, Presiding: | Ahmed F. Abdel-Magid | ||
| 8:30 AM | Introductory Remarks | ||
| 8:35 AM | 182 | Compound scale-up at the discovery-development interface Antonia Nikitenko, John R. Potoski | |
| 9:15 AM | 183 | Process development in an era of risk-based regulatory perspective Simon Leung, Ehrlic Lo, Mourad Hamedi, Eric Dowdy, Daniel Watson, Ariel Hou | |
| 9:55 AM | 184 | Excitement of early development process research: Selecting the first route Frank Villani | |
| 10:35 AM | 185 | Varenicline tartrate: A chemical journey Stéphane Caron | |
| 11:15 AM | 186 | Development of practical syntheses of VEGFR inhibitors Robert D. Larsen, Yuelie Lu, Tingjian Xiang, Ben Zhi, Jean Baum, Pingli Liu, Liang Huang, Ying Chen, Xin Wang, Richard Crockett, Doug Overland, Craig Schulz, Shawn Eisenberg, Michael Martinelli | |
| 11:55 AM | Concluding Remarks | ||
Symposium Grid -- Division of Organic Chemistry -- Session Listing
The 231st ACS National Meeting, Atlanta, GA, March 26-30, 2006